Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03973138
What this trial is testing

Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab

Who this might be right for
Diabetic Macular Edema
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116890
What this trial is testing

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Kyowa Kirin Co., Ltd. 180
Early research (Phase 1)Study completedNCT00791570
What this trial is testing

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

Who this might be right for
Neovascular MaculopathyAge Related Macular Degeneration
Osaka University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05984927
What this trial is testing

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Elisigen, Inc. 20
Not applicableStudy completedNCT00612261
What this trial is testing

Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion

Who this might be right for
Macular EdemaBranch Retinal Vein Occlusion
Yonsei University 40
Testing effectiveness (Phase 2)Study completedNCT02121522
What this trial is testing

A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Boehringer Ingelheim 14
Not applicableStudy completedNCT00055029
What this trial is testing

Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis

Who this might be right for
Retinoschisis
National Eye Institute (NEI) 351
Not applicableStudy completedNCT05963646
What this trial is testing

Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study

Who this might be right for
Age-Related Macular DegenerationGeographic AtrophyVisual Field Defect, Central Scotoma of Both Eyes
Institute of Molecular and Clinical Ophthalmology Basel 30
Large-scale testing (Phase 3)Study completedNCT02540954
What this trial is testing

Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Macular Degeneration
Bayer 336
Testing effectiveness (Phase 2)Study completedNCT00447954
What this trial is testing

An Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration

Who this might be right for
Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage
Neurotech Pharmaceuticals 53
Not applicableStudy completedNCT01204541
What this trial is testing

A Single-Center Pilot Study to Assess Macular Function

Who this might be right for
Macular Degeneration
ORA, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01570790
What this trial is testing

Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Combretastatin A4 PhosphateAge-related Macular DegenerationAMD+2 more
Johns Hopkins University 8
Not applicableStudy completedNCT06381596
What this trial is testing

Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
University of Wisconsin, Madison 32
Not applicableStudy completedNCT03509623
What this trial is testing

Blood Coagulation Parameters in Patients Receiving Intravitreal Aflibercept for Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
University Hospital of Patras 47
Not applicableActive Not RecruitingNCT04932980
What this trial is testing

Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Berner Augenklinik 80
Not applicableStudy completedNCT03324542
What this trial is testing

Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan

Who this might be right for
AMD
Changhua Christian Hospital 63
Not applicableStudy completedNCT00596388
What this trial is testing

Usage of the Home Macular Perimeter (HMP)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 20
Not applicableStudy completedNCT03878420
What this trial is testing

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II)

Who this might be right for
Dry Age-related Macular Degeneration
LumiThera, Inc. 44
Large-scale testing (Phase 3)Study completedNCT02307682
What this trial is testing

Efficacy and Safety of RTH258 Versus Aflibercept - Study 1

Who this might be right for
Neovascular Age-Related Macular DegenerationChoroidal Neovascularization
Alcon Research 1,775
Post-approval studies (Phase 4)Study completedNCT00751361
What this trial is testing

Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial

Who this might be right for
Dry Age Related Macular Degeneration
Apheresis Research Institute 52
Next Page